You’re on our free ad-supported tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Biogen
Biotech
Topics

Advertisement

Biogen

Share

Top Latest Popular

Yesterday

Biogen Taps Biopharmaceutical Veteran as Chief Legal Officer Bloomberg Law 16:38 Thu, 16 Jul

US biotech Biogen hires Spur Therapeutics CEO as next legal chief The Global Legal Post 11:20 Thu, 16 Jul

AAIC26: Biogen stock drops after unveiling tau-targeting ASO data Clinical Trials Arena 09:54 Thu, 16 Jul

Advertisement

Advertisement

Wednesday

Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data Zacks 17:02 Wed, 15 Jul

STAT Plus: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more STAT 14:10 Wed, 15 Jul

Biogen Appoints Michael J. Parini as Chief Legal Officer Biogen (Press Release) 13:23 Wed, 15 Jul

Biogen: Leqembi Real-World leader Study Shows Majority Of Early Alzheimer's Patients Remain Stable RTT News 08:55 Wed, 15 Jul

Biogen and Eisai’s Leqembi study shows nearly 83% of early Alzheimer’s patients remained stable or improved PMLiVE 08:20 Wed, 15 Jul

Tuesday

New experimental Alzheimer’s drug shows potential after study shows slower cognitive decline Fortune 23:38 Tue, 14 Jul

Biogen Wins FDA Approval for Subcutaneous Starter Dose of Leqembi Zacks 18:24 Tue, 14 Jul

Biogen, Ionis trumpet Alzheimer's data, but shares dip pharmaphorum 17:57 Tue, 14 Jul

New Alzheimer's Drug Targets Different Brain Protein NewsMax 17:51 Tue, 14 Jul

Biogen’s Diranersen Efficacy Similar To Leqembi On Key Alzheimer’s Endpoint Scrip Pharma Intelligence 17:27 Tue, 14 Jul

Eisai, Biogen Push Full SC Leqembi With FDA Nod As Alzheimer’s Market Competition Builds Scrip Pharma Intelligence 17:27 Tue, 14 Jul

Aaic 2026: Diranersen shines on clinical data in Celia trial BioWorld 17:10 Tue, 14 Jul

Biogen Stock Falls 9% Despite Reporting Encouraging Data From Diranersen Study RTT News 16:16 Tue, 14 Jul

Experimental Alzheimer's drug shows some promise as researchers hunt new approaches ABC News 15:24 Tue, 14 Jul

Biogen's Phase 2 Celia Study Shows Robust Tau Reduction And Cognitive Benefit In Early Alzheimer's RTT News 15:15 Tue, 14 Jul

Advertisement

Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs BioPharma Dive 14:51 Tue, 14 Jul

An experimental Alzheimer's drug shows some promise as researchers hunt new approaches MailOnline 14:28 Tue, 14 Jul

Ionis Partner Biogen Presents Phase 2 Celia Data at Aaic Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease Business Wire (Press Release) 14:26 Tue, 14 Jul

STAT Plus: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study shows STAT 14:23 Tue, 14 Jul

Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease Biogen (Press Release) 14:16 Tue, 14 Jul

FDA clears at-home start dose for Alzheimer's drug Leqembi pharmaphorum 09:48 Tue, 14 Jul

FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug The Economic Times 04:22 Tue, 14 Jul

Monday

FDA Approves Leqembi Iqlik® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease PR Newswire (Press Release) 22:38 Mon, 13 Jul

FDA Approves At-Home Starter Dose of Alzheimer's Drug NewsMax 21:06 Mon, 13 Jul

STAT Plus: All eyes on data on Biogen’s tau therapy STAT 14:45 Mon, 13 Jul

This Biogen Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday Benzinga 12:16 Mon, 13 Jul

Sunday

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026 Biogen (Press Release) 16:27 Sun, 12 Jul

In the last month

NRG Energy Now #302 Largest Company, Surpassing Biogen Nasdaq 22:17 Fri, 10 Jul

Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight PR Newswire (Press Release) 15:35 Thu, 09 Jul

Biogen's Q2 2026 Earnings: What to Expect Barchart 13:35 Thu, 09 Jul

Why Biogen (BIIB) is Poised to Beat Earnings Estimates Again Zacks 18:12 Tue, 07 Jul

Biogen to Webcast from the Alzheimer's Association International Conference (AAIC) July 14, 2026 Biogen (Press Release) 12:13 Tue, 07 Jul

How AAIC 2026 Alzheimer’s Data Releases Could Reframe Biogen (BIIB) Investors’ Long‑Term Thesis Simply Wall St 13:02 Mon, 06 Jul

Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors. The Motley Fool 09:21 Sat, 04 Jul

Amgen or Biogen: Which Biotech Stock Appears Better Poised? Zacks 15:10 Wed, 01 Jul

Italy: Italian Competition Authority launches investigation into Biogen Italia Srl and its parent company Biogen Inc over possible abuse of dominant position Thomson Reuters - Practical Law 10:40 Tue, 30 Jun

Biogen: Key Takeaways From Needham’s Meeting With Top Management Benzinga 16:34 Mon, 29 Jun

Advertisement

Advertisement

About our Biogen News

Biogen is an American multinational biotechnology company that specialises in treatment of neurological diseases.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna